Our News
Alnylam's Paul Nioi, PhD on The Genetics Podcast: Using Genetics in Drug Target Discovery
March 16, 2023
Alnylam Pharmaceuticals
Paul Nioi, PhD, VP of Discovery and Translational Research and Head of Alnylam Human Genetics recently spoke with Dr. Patrick Short on The Genetics Podcast. Paul discussed how Alnylam uses genetics in the development of new medicines, why we feel that genetically validated targets have a higher probability of success in the clinic and highlights some of our recent work. He and Patrick also talked about Alnylam's significant investments in genetics capabilities and our involvement in genetics database projects including the UK Biobank and Our Future Health. To dig deeper, learn more about how genetics is driving discovery of Alnylam's next wave of RNAi therapeutics and the the science of RNAi (RNA interference).
Since 2019, The Genetics Podcast has been been exploring all things genetics through interviews with the people and companies driving breakthroughs in genetics research. Check out all of their episodes here.
